1-3 of 3
Mark Lipstein, B.S.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complementary Targeting of PI3K and the Proteasome Causes Potent Inhibition of mTORC1 and NF-Kappab in Models of B- and T-Cell Lymphoma

Changchun Deng, MD PhD, Mark Lipstein, B.S., Xavier Jirau Serrano, Michael Mangone, PhD, Luigi Scotto, PhD, Owen A O'Connor, MD, PhD, Peter Sportelli, Hari P. Miskin, MS, Srikant Viswanadha, PhD
Journal: Blood
Blood (2014) 124 (21): 1770.
https://doi.org/10.1182/blood.V124.21.1770.1770
Published: 2014
Journal Articles

The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells

Changchun Deng, M.D, PH.D., Christine McIntosh, Richard Rodriguez, B.S., Peter Sportelli, Hari P. Miskin, MS, Swaroop Vakkalanka, PhD, Srikant Viswanadha, Ph.D., Mark Lipstein, B.S., Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4421.
https://doi.org/10.1182/blood.V122.21.4421.4421
Published: 2013
Journal Articles

Combination Of Selective HDAC Inhibitors That Target Specific HDAC Isoforms Synergistically Inhibits T Cell Lymphoma

Changchun Deng, MD, PhD, Richard Rodriguez, B.S., Christine McIntosh, Edward Holson, PH.D., Charles Karan, PH.D., Mark Lipstein, B.S., Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5142.
https://doi.org/10.1182/blood.V122.21.5142.5142
Published: 2013